THE BASIC PRINCIPLES OF PANOBINOSTAT

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely designed TPD procedures. In this evaluation, we target both of those preclinical experiments and clinical trials to deliver a comprehensive summary of the protection and medical efficiency of PROTACs and MGDs in hematologic malignancies